• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏结节病相关心律失常的管理

Management of Arrhythmias Associated with Cardiac Sarcoidosis.

作者信息

Yada Hirotaka, Soejima Kyoko

机构信息

Department of Cardiology, National Defense Medical College, Tokorozawa, Japan.

Department of Cardiology, Kyorin University School of Medicine, Tokyo, Japan.

出版信息

Korean Circ J. 2019 Feb;49(2):119-133. doi: 10.4070/kcj.2018.0432.

DOI:10.4070/kcj.2018.0432
PMID:30693680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6351276/
Abstract

Sarcoidosis is a multisystem granulomatous disorder of unknown etiology. The annual incidence of systemic sarcoidosis is estimated at 10-20 per 100,000 individuals. Owing to the recent advances in imaging modalities, cardiac sarcoidosis (CS) is diagnosed more frequently. The triad of CS includes conduction abnormality, ventricular tachycardia, and heart failure. Atrial and ventricular arrhythmias are caused by either inflammation or scar formation. Inflammation should be treated with immunosuppression and antiarrhythmic agents and scar formation should be treated with antiarrhythmics and/or ablation, in addition to implantable cardioverter defibrillator (ICD) implantation, if necessary. Ablation can provide a good outcome, but it might require bipolar ablation if the critical portion is located mid-myocardium. Late recurrence might be caused by reactivation of sarcoidosis, which would need to be evaluated by positron emission tomography-computed tomography imaging. Risk of sudden cardiac death (SCD) in patients with advanced atrioventricular block is not low, and ICD implantation could be considered instead of a pacemaker. For risk stratification for SCD, late gadolinium enhancement by cardiac magnetic resonance imaging or program stimulation is often used.

摘要

结节病是一种病因不明的多系统肉芽肿性疾病。系统性结节病的年发病率估计为每10万人中有10 - 20例。由于成像技术的最新进展,心脏结节病(CS)的诊断更为频繁。CS的三联征包括传导异常、室性心动过速和心力衰竭。房性和室性心律失常是由炎症或瘢痕形成引起的。炎症应采用免疫抑制和抗心律失常药物治疗,瘢痕形成除必要时植入植入式心脏复律除颤器(ICD)外,应采用抗心律失常药物和/或消融治疗。消融可以取得良好的效果,但如果关键部位位于心肌中层,可能需要双极消融。晚期复发可能由结节病的重新激活引起,这需要通过正电子发射断层扫描 - 计算机断层扫描成像进行评估。晚期房室传导阻滞患者的心脏性猝死(SCD)风险不低,可以考虑植入ICD而非起搏器。对于SCD的风险分层,通常使用心脏磁共振成像的延迟钆增强或程序刺激。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7987/6351276/59a2607a5d42/kcj-49-119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7987/6351276/b4075e16a268/kcj-49-119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7987/6351276/59a2607a5d42/kcj-49-119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7987/6351276/b4075e16a268/kcj-49-119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7987/6351276/59a2607a5d42/kcj-49-119-g002.jpg

相似文献

1
Management of Arrhythmias Associated with Cardiac Sarcoidosis.心脏结节病相关心律失常的管理
Korean Circ J. 2019 Feb;49(2):119-133. doi: 10.4070/kcj.2018.0432.
2
Applicability of the AHA/ACC/HRS Guideline for Implantable Cardioverter Defibrillator Implantation in Japanese Patients With Cardiac Sarcoidosis.日本心脏结节病患者植入式心脏复律除颤器植入的 AHA/ACC/HRS 指南适用性。
JACC Clin Electrophysiol. 2021 Nov;7(11):1410-1418. doi: 10.1016/j.jacep.2021.04.009. Epub 2021 Jun 30.
3
Automatic Implantable Cardioverter Defibrillator (AICD) Implantation as Secondary Prevention of Cardiac Sarcoidosis-Associated Ventricular Tachycardia.植入式自动心脏复律除颤器(AICD)植入作为心脏结节病相关室性心动过速二级预防的手段
Eur J Case Rep Intern Med. 2024 May 2;11(6):004469. doi: 10.12890/2024_004469. eCollection 2024.
4
Ventricular Arrhythmias in Cardiac Sarcoidosis.心脏结节病中的室性心律失常。
Circulation. 2018 Sep 18;138(12):1253-1264. doi: 10.1161/CIRCULATIONAHA.118.034687.
5
Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.疑似左、右心室收缩功能正常的心脏结节病患者的诊断评估和危险分层的电生理检查。
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1939-1948. doi: 10.1111/jce.14058. Epub 2019 Jul 23.
6
Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.介入电生理学及其在心律失常治疗中的作用。
Ann Acad Med Singap. 1998 Mar;27(2):248-54.
7
Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.心脏结节病患者和植入式心脏复律除颤器的长期随访。
Heart Rhythm. 2012 Jun;9(6):884-91. doi: 10.1016/j.hrthm.2012.02.010. Epub 2012 Feb 13.
8
Atrial Fibrillation and Ventricular Tachycardia in a Patient with Cardiac Sarcoidosis.心脏结节病患者的心房颤动和室性心动过速
J Innov Card Rhythm Manag. 2018 Feb 15;9(2):3016-3021. doi: 10.19102/icrm.2018.090203. eCollection 2018 Feb.
9
Electrophysiologic manifestations of cardiac sarcoidosis.心脏结节病的电生理表现。
Curr Opin Pulm Med. 2013 Sep;19(5):485-92. doi: 10.1097/MCP.0b013e3283644c6f.
10
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.心脏结节病患者心室内性心动过速导管消融的相关结局。
JAMA Cardiol. 2022 Feb 1;7(2):175-183. doi: 10.1001/jamacardio.2021.4738.

引用本文的文献

1
Emerging Insights into Granulomatous and Amyloidogenic Cardiomyopathies.对肉芽肿性和淀粉样变性心肌病的新见解
J Clin Med. 2025 Jun 13;14(12):4208. doi: 10.3390/jcm14124208.
2
Oxidative Stress, Antioxidant Capacity, and Inflammatory Markers in Patients with Idiopathic Complete Heart Block.特发性完全性心脏传导阻滞患者的氧化应激、抗氧化能力及炎症标志物
Heart Views. 2024 Jul-Sep;25(3):133-138. doi: 10.4103/heartviews.heartviews_43_24. Epub 2025 Jan 4.
3
Perioperative management of patients with cardiac implantable electronic devices.

本文引用的文献

1
Management of refractory ventricular tachycardia due to cardiac sarcoidosis-A biologic approach.心脏结节病所致难治性室性心动过速的管理——一种生物学方法。
HeartRhythm Case Rep. 2018 Nov 16;5(2):97-100. doi: 10.1016/j.hrcr.2018.11.004. eCollection 2019 Feb.
2
Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.以高度房室传导阻滞为表现的心肌结节病的转归。
Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006145. doi: 10.1161/CIRCEP.117.006145.
3
Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation.
心脏植入式电子设备患者的围手术期管理。
Korean J Anesthesiol. 2024 Jun;77(3):306-315. doi: 10.4097/kja.23826. Epub 2024 Jan 29.
4
Association of Arrhythmias in Cardiac Amyloidosis and Cardiac Sarcoidosis.心脏淀粉样变性和心脏结节病中心律失常的关联
Cureus. 2020 Aug 18;12(8):e9842. doi: 10.7759/cureus.9842.
心脏结节病的电解剖基质特征:与瘢痕和炎症的影像学发现的相关性。
JACC Clin Electrophysiol. 2018 Mar;4(3):291-303. doi: 10.1016/j.jacep.2017.09.175. Epub 2017 Nov 29.
4
Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.心脏磁共振成像与正电子发射断层扫描/计算机断层扫描在心脏结节病评估中的互补价值。
Circ Cardiovasc Imaging. 2018 Jan;11(1):e007030. doi: 10.1161/CIRCIMAGING.117.007030.
5
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.18F-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像在心脏结节病中的诊断准确性和预后价值。
Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):757-767. doi: 10.1093/ehjci/jex340.
6
Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: Electrophysiological characteristics, mapping, and ablation of underlying heart disease.非缺血性心肌病与右心室瘢痕相关的室性心动过速:电生理特征、标测和消融基础心脏病。
J Cardiovasc Electrophysiol. 2018 Jan;29(1):79-89. doi: 10.1111/jce.13346. Epub 2017 Nov 3.
7
Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on F-FDG PET Scans for Suspected Cardiac Sarcoidosis.可疑心脏结节病 F-FDG PET 扫描异常程度、严重程度和异质性对预后的影响。
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):336-345. doi: 10.1016/j.jcmg.2017.04.020. Epub 2017 Aug 16.
8
Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.心脏结节病患者室性心动过速的导管消融:系统评价。
Europace. 2018 Apr 1;20(4):682-691. doi: 10.1093/europace/eux077.
9
Long-Term Outcome After Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Dilated Cardiomyopathy.非缺血性扩张型心肌病患者室性心动过速导管消融术后的长期预后
Circ Arrhythm Electrophysiol. 2016 Oct;9(10). doi: 10.1161/CIRCEP.116.004328.
10
The wearable cardioverter-defibrillator: current technology and evolving indications.可穿戴式心脏复律除颤器:当前技术与不断演变的适应症
Europace. 2017 Mar 1;19(3):335-345. doi: 10.1093/europace/euw180.